Tenax adopts CIC/Severance Plans; amends CEO Giordano's agreement

TENAX THERAPEUTICS, INC.

Board adopted double-trigger Change in Control Plan and Severance Plan on June 26, 2026.
CEO Giordano: 18 months' base salary + target bonus + accelerated vesting on CIC termination.
Executives Staab and Rich: 12 months' base salary + COBRA on CIC; non-CIC severance includes 12-month base plus extra base per year of service up to 12 additional months.
Benefits under plans and amendments conditioned on execution of release of claims.
Executive officers excluded from new plans; covered via individual amended agreements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.